Affinity Asset Advisors »

Rezolute shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Rezolute (RZLT) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Rezolute

Tip: Access up to 7 years of quarterly data

All positions including Rezolute held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rezolute by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $8.0M 1.9M 4.30
2024-03-31 $4.1M 1.6M 2.55

More positions owned by Affinity Asset Advisors

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Xenon Pharmaceuticals (XENE)
Apogee Therapeutics (APGE)
Madrigal Pharmaceuticals (MDGL)
Cerevel Therapeutics Hldng I (CERE)
Arcellx Common Stock (ACLX)
Crinetics Pharmaceuticals In (CRNX)
Nurix Therapeutics (NRIX)
Celldex Therapeutics Com New (CLDX)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Alnylam Pharmaceuticals Note 1.000% 9/1 (Principal)
Beigene Sponsored Adr (BGNE)
Alkermes SHS (ALKS)
Nuvalent Inc-a (NUVL)

View all positions for Affinity Asset Advisors

Top funds holding Rezolute

Federated Investors
Nantahala Capital Management
Affinity Asset Advisors
Blackstone Group
Sphera Funds Management
Altium Capital Management
Vanguard Group
Ghost Tree Capital
Alyeska Investment Group
Marshall Wace
Ikarian Capital
Morgan Stanley
BlackRock
Geode Capital Management
Citadel Advisors

View all funds holding Rezolute